Robert G Hart

Summary

Affiliation: University of Texas Health Science Center
Country: USA

Publications

  1. ncbi request reprint Atrial fibrillation, stroke, and acute antithrombotic therapy: analysis of randomized clinical trials
    Robert G Hart
    Department of Medicine Neurology, University of Texas Health Science Center, San Antonio 78229 3900, USA
    Stroke 33:2722-7. 2002
  2. ncbi request reprint What's new in stroke? The top 10 studies of 2006-2008. Part I
    Robert G Hart
    Department of Neurology, University of Texas Health Science Center, San Antonio, TX 78229, USA
    Pol Arch Med Wewn 118:650-7. 2008
  3. doi request reprint Neuroprotection trials in Parkinson's disease: systematic review
    Robert G Hart
    Department of Neurology, University of Texas Health Science Center, San Antonio, Texas 78229 3900, USA
    Mov Disord 24:647-54. 2009
  4. doi request reprint Clopidogrel and aspirin versus aspirin alone for the prevention of stroke in patients with a history of atrial fibrillation: subgroup analysis of the CHARISMA randomized trial
    Robert G Hart
    Department of Neurology, University of Texas Health Science Center, San Antonio, TX 78229 3900, USA
    Cerebrovasc Dis 25:344-7. 2008
  5. ncbi request reprint An assessment of guidelines for prevention of ischemic stroke
    Robert G Hart
    Department of Medicine Neurology, University of Texas Health Science Center, San Antonio, 78229 3900, USA
    Neurology 59:977-82. 2002
  6. ncbi request reprint Anticoagulation in atrial fibrillation: selected controversies including optimal anticoagulation intensity, treatment of intracerebral hemorrhage
    Robert G Hart
    Department of Medicine Neurology, University of Texas Health Science Center, San Antonio, TX 78229, USA
    J Thromb Thrombolysis 25:26-32. 2008
  7. ncbi request reprint Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation
    Robert G Hart
    Department of Medicine Neurology, University of Texas Health Science Center, San Antonio, Texas 78229 3900, USA
    Ann Intern Med 146:857-67. 2007
  8. ncbi request reprint Avoiding central nervous system bleeding during antithrombotic therapy: recent data and ideas
    Robert G Hart
    Department of Medicine, University of Texas Health Science Center, San Antonio, TX 78229 3900, USA
    Stroke 36:1588-93. 2005
  9. ncbi request reprint Lessons from the Stroke Prevention in Atrial Fibrillation trials
    Robert G Hart
    Department of Medicine Neurology, University of Texas Health Science Center, 7703 Floyd Curl Drive MC 7883, San Antonio, Texas 78229 3900, USA
    Ann Intern Med 138:831-8. 2003
  10. ncbi request reprint What's new in stroke? The top 10 studies of 2006-2008. Part II
    Robert G Hart
    Vascular Neurology, Department of Neurology, University of Texas Health Science Center, San Antonio, TX 78229, USA
    Pol Arch Med Wewn 118:747-55. 2008

Detail Information

Publications64

  1. ncbi request reprint Atrial fibrillation, stroke, and acute antithrombotic therapy: analysis of randomized clinical trials
    Robert G Hart
    Department of Medicine Neurology, University of Texas Health Science Center, San Antonio 78229 3900, USA
    Stroke 33:2722-7. 2002
    ..Until recently, the value of antithrombotic therapies for acute stroke management has been based on empiric evidence...
  2. ncbi request reprint What's new in stroke? The top 10 studies of 2006-2008. Part I
    Robert G Hart
    Department of Neurology, University of Texas Health Science Center, San Antonio, TX 78229, USA
    Pol Arch Med Wewn 118:650-7. 2008
    ..These trials, together involving 39,742 participants, have influenced 2008 European and North American guidelines for secondary prevention of noncardioembolic stroke, and these guideline recommendations are reviewed...
  3. doi request reprint Neuroprotection trials in Parkinson's disease: systematic review
    Robert G Hart
    Department of Neurology, University of Texas Health Science Center, San Antonio, Texas 78229 3900, USA
    Mov Disord 24:647-54. 2009
    ..Future trials should include participants with wider ranges of disease stages and assess broader neurological outcomes...
  4. doi request reprint Clopidogrel and aspirin versus aspirin alone for the prevention of stroke in patients with a history of atrial fibrillation: subgroup analysis of the CHARISMA randomized trial
    Robert G Hart
    Department of Neurology, University of Texas Health Science Center, San Antonio, TX 78229 3900, USA
    Cerebrovasc Dis 25:344-7. 2008
    ..Aspirin offers modest reduction in stroke in patients with atrial fibrillation. Whether combination of aspirin with clopidogrel offers additional protection is unclear...
  5. ncbi request reprint An assessment of guidelines for prevention of ischemic stroke
    Robert G Hart
    Department of Medicine Neurology, University of Texas Health Science Center, San Antonio, 78229 3900, USA
    Neurology 59:977-82. 2002
    ..To compare methods and key management recommendations from recent stroke prevention guidelines...
  6. ncbi request reprint Anticoagulation in atrial fibrillation: selected controversies including optimal anticoagulation intensity, treatment of intracerebral hemorrhage
    Robert G Hart
    Department of Medicine Neurology, University of Texas Health Science Center, San Antonio, TX 78229, USA
    J Thromb Thrombolysis 25:26-32. 2008
    ..A wide range of acute treatments to urgently reverse anticoagulation have been recommended by experts, but prevention is a far better option than treatment of this devastating problem...
  7. ncbi request reprint Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation
    Robert G Hart
    Department of Medicine Neurology, University of Texas Health Science Center, San Antonio, Texas 78229 3900, USA
    Ann Intern Med 146:857-67. 2007
    ..Atrial fibrillation is a strong independent risk factor for stroke...
  8. ncbi request reprint Avoiding central nervous system bleeding during antithrombotic therapy: recent data and ideas
    Robert G Hart
    Department of Medicine, University of Texas Health Science Center, San Antonio, TX 78229 3900, USA
    Stroke 36:1588-93. 2005
    ..We review the incidence, risk factors, and predictors of ICH in patients receiving long-term anticoagulation or antiplatelet therapy...
  9. ncbi request reprint Lessons from the Stroke Prevention in Atrial Fibrillation trials
    Robert G Hart
    Department of Medicine Neurology, University of Texas Health Science Center, 7703 Floyd Curl Drive MC 7883, San Antonio, Texas 78229 3900, USA
    Ann Intern Med 138:831-8. 2003
    ..For patients at moderate risk for stroke, patient preferences and access to reliable anticoagulation monitoring are particularly relevant...
  10. ncbi request reprint What's new in stroke? The top 10 studies of 2006-2008. Part II
    Robert G Hart
    Vascular Neurology, Department of Neurology, University of Texas Health Science Center, San Antonio, TX 78229, USA
    Pol Arch Med Wewn 118:747-55. 2008
    ..These recent studies add important pieces to the complex puzzle of optimal stroke prevention and treatment...
  11. ncbi request reprint What's new in stroke? The top 10 studies of 2009-2011: part II
    Robert G Hart
    Vascular Neurology, Department of Neurology, University of Texas Health Science Center, San Antonio, United States
    Pol Arch Med Wewn 121:200-7. 2011
    ..For younger patients, periprocedural risks were comparable with stenting or endarterectomy, but long-term outcomes are required to assess the relative merits of the two procedures...
  12. ncbi request reprint Factors associated with ischemic stroke during aspirin therapy in atrial fibrillation: analysis of 2012 participants in the SPAF I-III clinical trials. The Stroke Prevention in Atrial Fibrillation (SPAF) Investigators
    R G Hart
    University of Texas Health Science Center, San Antonio, TX, USA
    Stroke 30:1223-9. 1999
    ..We explore factors associated with ischemic stroke in AF patients taking aspirin...
  13. ncbi request reprint Transient ischemic attacks in patients with atrial fibrillation: implications for secondary prevention: the European Atrial Fibrillation Trial and Stroke Prevention in Atrial Fibrillation III trial
    Robert G Hart
    Department of Medicine, University of Texas Health Science Center, 7703 Floyd Curl Dr, MSC 7883, San Antonio, TX 78229 3900, USA
    Stroke 35:948-51. 2004
    ..Transient ischemic attacks (TIAs) are infrequent in patients with atrial fibrillation, and little is known about the long-term prognosis and response to antithrombotic therapy...
  14. ncbi request reprint Increased risk of intracranial hemorrhage when aspirin is combined with warfarin: A meta-analysis and hypothesis
    R G Hart
    Department of Medicine Division of Neurology, University of Texas Health Science Center in San Antonio, TX 78284 7883, USA
    Cerebrovasc Dis 9:215-7. 1999
    ..Oral anticoagulation with vitamin K antagonists increases the risk of intracranial hemorrhage; whether addition of aspirin to oral anticoagulation augments this risk is unclear...
  15. ncbi request reprint Atrial fibrillation and thromboembolism: a decade of progress in stroke prevention
    R G Hart
    Department of Medicine Neurology, University of Texas Health Sciences Center, San Antonio 78284, USA
    Ann Intern Med 131:688-95. 1999
    ..Making the most of this promise calls for appreciation of the epidemiology of atrial fibrillation and the concept of risk specificity in the face of diverse therapeutic options...
  16. ncbi request reprint Stroke with intermittent atrial fibrillation: incidence and predictors during aspirin therapy. Stroke Prevention in Atrial Fibrillation Investigators
    R G Hart
    Department of Medicine, University of Texas Health Science Center, San Antonio 78284, USA
    J Am Coll Cardiol 35:183-7. 2000
    ..This study was performed to characterize the risk of stroke in elderly patients with recurrent intermittent atrial fibrillation (AF)...
  17. ncbi request reprint Aspirin for the primary prevention of stroke and other major vascular events: meta-analysis and hypotheses
    R G Hart
    Department of Medicine Neurology, University of Texas Health Science Center, San Antonio 78284, USA
    Arch Neurol 57:326-32. 2000
    ..Aspirin therapy reduces stroke by about 25% for persons with atherosclerotic vascular disease, but the effect in those without clinically apparent vascular disease is distinctly different...
  18. ncbi request reprint Stroke prevention in atrial fibrillation
    R G Hart
    Department of Medicine Neurology, University of Texas Health Science Center, 7703 Floyd Curl Drive, San Antonio, TX 78284 7883, USA
    Curr Cardiol Rep 2:51-5. 2000
    ..For those with moderate stroke risk, individual bleeding risks during anticoagulation and patient preferences should guide antithrombotic therapy...
  19. pmc Warfarin in atrial fibrillation patients with moderate chronic kidney disease
    Robert G Hart
    Department of Neurology, University of Texas Health Science Center, San Antonio, TX 78229 3900, USA
    Clin J Am Soc Nephrol 6:2599-604. 2011
    ..The efficacy of adjusted-dose warfarin for prevention of stroke in atrial fibrillation patients with stage 3 chronic kidney disease (CKD) is unknown...
  20. ncbi request reprint What's new in stroke? The top 10 for 2004/05
    Silvina B Tonarelli
    Department of Medicine Neurology, University of Texas Health Science Center, San Antonio, Texas 78229, USA
    J Am Geriatr Soc 54:674-9. 2006
    ..The practical management implications of these studies refine and improve care of geriatric patients with cerebrovascular disease...
  21. doi request reprint Effect of addition of clopidogrel to aspirin on mortality: systematic review of randomized trials
    Santiago Palacio
    Department of Neurology, University of Texas Health Science Center, San Antonio, Texas 78229 3900, USA
    Stroke 43:2157-62. 2012
    ..We assessed the effect of the addition of clopidogrel to aspirin on mortality in a meta-analysis of published randomized trials...
  22. ncbi request reprint Treatment of warfarin-associated intracerebral hemorrhage: literature review and expert opinion
    Maria I Aguilar
    Department of Neurology, Mayo Clinic College of Medicine, 13400 E Shea Blvd, Scottsdale, AZ 85259, USA
    Mayo Clin Proc 82:82-92. 2007
    ..Reasonable management based on expert opinion includes a wide range of additional measures to reverse anticoagulation in the absence of solid evidence...
  23. ncbi request reprint Atrial fibrillation and stroke prevention
    Robert G Hart
    Department of Medicine, Division of Neurology, University of Texas Health Science Center, San Antonio, USA
    N Engl J Med 349:1015-6. 2003
  24. ncbi request reprint Occurrence and characteristics of stroke events in the Atrial Fibrillation Follow-up Investigation of Sinus Rhythm Management (AFFIRM) study
    David G Sherman
    University of Texas Health Science Center, San Antonio, USA
    Arch Intern Med 165:1185-91. 2005
    ..The Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) Study was a multicenter comparison of high-risk patients with AF who were randomized to either a sinus rhythm control or a rate control strategy...
  25. ncbi request reprint Antithrombotic therapies for stroke prevention in atrial fibrillation
    Robert G Hart
    Department of Medicine Neurology, University of Texas Health Science Center, San Antonio, Texas, USA
    Adv Neurol 92:249-56. 2003
  26. ncbi request reprint Aspirin dosage and thromboxane synthesis in patients with vascular disease
    Robert G Hart
    University of Texas Health Science Center, San Antonio 78229 3900, USA
    Pharmacotherapy 23:579-84. 2003
    ..To determine whether urinary 11-dehydrothromboxane B2 (d-TXB2) is a marker of aspirin resistance and define the relationship between aspirin dosage and concentrations of this thromboxane metabolite...
  27. ncbi request reprint Reliability and validity of blood pressure measurement in the Secondary Prevention of Small Subcortical Strokes study
    Pablo E Pergola
    Department of Medicine, Division of Nephrology, University of Texas Health Science Center at San Antonio, San Antonio, TX 78229, USA
    Blood Press Monit 12:1-8. 2007
    ..Reliable and unbiased blood pressure measurement is critical to successful completion of the trial...
  28. ncbi request reprint Headache improvement through TMD stabilization appliance and self-management therapies
    Edward F Wright
    University of Texas Health Science Center, San Antonio, USA
    Cranio 24:104-11. 2006
    ..722). These results suggest appliance and self-management therapies can be beneficial for many severe headache patients, irrespective of the headache type (tension-type, migraine without aura, and migraine with aura)...
  29. ncbi request reprint Recurrent brain hemorrhage is more frequent than ischemic stroke after intracranial hemorrhage
    R D Bailey
    Department of Medicine Neurology, University of Texas Health Science Center, San Antonio, TX 78229 3900, USA
    Neurology 56:773-7. 2001
    ..To characterize the rates of recurrent intracranial hemorrhage (ICH), ischemic stroke, and death in survivors of primary ICH...
  30. ncbi request reprint Cerebral hemorrhage after intra-arterial thrombolysis for ischemic stroke: the PROACT II trial
    C S Kase
    Department of Neurology, Boston University School of Medicine, MA 02118, USA
    Neurology 57:1603-10. 2001
    ..To analyze the frequency, clinical characteristics, and predictors of symptomatic intracerebral hemorrhage (ICH) after intraarterial (IA) thrombolysis with recombinant pro-urokinase (r-proUK) in acute ischemic stroke...
  31. ncbi request reprint Transesophageal echocardiographic correlates of clinical risk of thromboembolism in nonvalvular atrial fibrillation. Stroke Prevention in Atrial Fibrillation III Investigators
    M Zabalgoitia
    University of Texas Health Science Center at San Antonio, 78284 7872, USA
    J Am Coll Cardiol 31:1622-6. 1998
    ..This study explored the mechanisms linking clinical and precordial echocardiographic predictors to thromboembolism in atrial fibrillation (AF) by assessing transesophageal echocardiographic (TEE) correlations...
  32. ncbi request reprint What's new in stroke? The top 10 studies of 2009-2011: part I
    Wiesław J Oczkowski
    Vascular Neurology, Division of Neurology, Department of Medicine, McMaster University, Hamilton, Ontario, Canada
    Pol Arch Med Wewn 121:193-9. 2011
    ....
  33. pmc Thrombolysis for acute stroke in hemodialysis: international survey of expert opinion
    Santiago Palacio
    Department of Neurology, University of Texas Health Science Center, 8300 Floyd Curl Drive MC 7883, San Antonio, TX 78229 3900, USA
    Clin J Am Soc Nephrol 6:1089-93. 2011
    ..The objective of this study was for stroke experts to define the range of management concerning thrombolytic treatment of acute stroke in hemodialysis...
  34. ncbi request reprint National Stroke Association guidelines for the management of transient ischemic attacks
    S Claiborne Johnston
    Department of Neurology, University of California, San Francisco, CA 94143 0114, USA
    Ann Neurol 60:301-13. 2006
    ..Management varies widely, and most published guidelines have not been updated in several years. We sought to create comprehensive, unbiased, evidence-based guidelines for the management of patients with transient ischemic attacks...
  35. pmc Stroke risk in an elderly population with atrial fibrillation
    W M Feinberg
    Department of Neurology, University of Arizona Health Sciences Center, Tucson, USA
    J Gen Intern Med 14:56-9. 1999
    ..7% per year (95% CI 0.6, 3.8). Many people with AF in this population-derived cohort had relatively low rates of stroke. Further studies to reliably stratify stroke risk in patients with AF are needed...
  36. ncbi request reprint Neurologic manifestations of cardiogenic embolism: an update
    Santiago Palacio
    Department of Medicine, Neurology, University of Texas Health Science Center, San Antonio, Texas 78229 3900, USA
    Neurol Clin 20:179-93, vii. 2002
    ..Their role as independent risk factors for stroke and management implications based on recent evidence, along with characterization of schemes for antithrombotic management of patients with atrial fibrillation are reviewed...
  37. ncbi request reprint Late-developing cerebral arteropathy after pyogenic meningitis
    Santiago Palacio
    Department of Medicine Neurology, The University of Texas Health Science Center at San Antonio, 7703 Floyd Curl Dr, San Antonio, Texas 78229 3900, USA
    Arch Neurol 60:431-3. 2003
    ..Although vasculopathy is a recognized complication during acute meningitis, to our knowledge, no previous reports have been published of this phenomenon developing months after successful treatment...
  38. pmc Antithrombotic therapy for atrial fibrillation
    Gregory Y H Lip
    University Department of Medicine, City Hospital, Birmingham
    BMJ 325:1022-5. 2002
  39. ncbi request reprint Oral anticoagulants vs. aspirin for stroke prevention in patients with non-valvular atrial fibrillation: the verdict is in
    Carl van Walraven
    Clinical Epidemiology Unit Ottawa Health Research Institute, Ottawa, Ontario, Canada
    Card Electrophysiol Rev 7:374-8. 2003
    ..Since high-risk AF patients appear to benefit most from OAC, determining stroke risk in AF patients is very important...
  40. ncbi request reprint Adjusted-dose warfarin versus aspirin for preventing stroke in patients with atrial fibrillation
    Robert G Hart
    Ann Intern Med 147:590-2. 2007
  41. ncbi request reprint Plasma von Willebrand factor and soluble p-selectin as indices of endothelial damage and platelet activation in 1321 patients with nonvalvular atrial fibrillation: relationship to stroke risk factors
    Dwayne S G Conway
    Haemostasis Thrombosis and Vascular Biology Unit, University Department of Medicine, City Hospital, Birmingham, England
    Circulation 106:1962-7. 2002
    ..We hypothesized that stroke risk factors may be associated with increased endothelial damage/dysfunction and platelet activation among patients with AF...
  42. ncbi request reprint Did we really need another comparison of warfarin with aspirin? An assessment of the BAFTA trial
    Robert G Hart
    Pol Arch Med Wewn 117:443-5. 2007
  43. doi request reprint Risks and benefits of oral anticoagulation compared with clopidogrel plus aspirin in patients with atrial fibrillation according to stroke risk: the atrial fibrillation clopidogrel trial with irbesartan for prevention of vascular events (ACTIVE-W)
    Jeff S Healey
    Population Health Research Institute, McMaster University, 237 Barton St E, Hamilton, Ontario, Canada
    Stroke 39:1482-6. 2008
    ..However, because OAC carries important bleeding complications, risk stratification schemes have been devised to identify patients for whom the absolute benefits of OAC exceed its risks...
  44. ncbi request reprint Carotid-artery stenting versus endarterectomy
    Silvina B Tonarelli
    N Engl J Med 352:624-7; author reply 624-7. 2005
  45. ncbi request reprint Making anticoagulation safer
    Robert G Hart
    Neurology 59:153. 2002
  46. ncbi request reprint Do we really need a better way to give heparin in acute cerebral ischemia?
    Robert G Hart
    Stroke 33:659-60. 2002
  47. ncbi request reprint High-sensitivity C-reactive protein and soluble CD40 ligand as indices of inflammation and platelet activation in 880 patients with nonvalvular atrial fibrillation: relationship to stroke risk factors, stroke risk stratification schema, and prognosis
    Gregory Y H Lip
    Haemostasis Thrombosis and Vascular Biology Unit, University Department of Medicine, City Hospital, Birmingham, England, UK
    Stroke 38:1229-37. 2007
    ....
  48. pmc ABC of antithrombotic therapy: Antithrombotic therapy for cerebrovascular disorders
    Gregory Y H Lip
    BMJ 325:1161-3. 2002
  49. ncbi request reprint Oral anticoagulants vs aspirin in nonvalvular atrial fibrillation: an individual patient meta-analysis
    Carl van Walraven
    Clinical Epidemiology Unit, Ottawa Health Research Institute, F 6, Ottawa Hospital, Civic Campus, 1053 Carling Ave, Ottawa, Ontario, Canada K1Y 4E9
    JAMA 288:2441-8. 2002
    ..Patients with nonvalvular atrial fibrillation (AF) have an increased risk of stroke and other vascular events...
  50. ncbi request reprint Prognostic value of plasma von Willebrand factor and soluble P-selectin as indices of endothelial damage and platelet activation in 994 patients with nonvalvular atrial fibrillation
    Dwayne S G Conway
    Haemostasis Thrombosis and Vascular Biology Unit, University Department of Medicine, City Hospital, Birmingham, England
    Circulation 107:3141-5. 2003
    ..We hypothesized that raised plasma levels of von Willebrand factor (vWf, an index of endothelial damage/dysfunction) and/or soluble P-selectin (sP-sel, an index of platelet activation) might predict vascular events in AF...
  51. ncbi request reprint A clinical prediction rule to identify patients with atrial fibrillation and a low risk for stroke while taking aspirin
    Carl van Walraven
    Clinical Epidemiology Unit, Ottawa Health Research Institute, Ottawa Hospital, Ontario, Canada
    Arch Intern Med 163:936-43. 2003
    ....
  52. ncbi request reprint Perindopril-based blood pressure-lowering reduces major vascular events in patients with atrial fibrillation and prior stroke or transient ischemic attack
    Hisatomi Arima
    George Institute for International Health, University of Sydney, Australia
    Stroke 36:2164-9. 2005
    ..The primary objective here is to determine whether routine blood pressure-lowering provides additional protection for this high-risk patient group...
  53. ncbi request reprint Anticoagulation intensity and stroke during warfarin-use in atrial fibrillation patients
    Robert G Hart
    Stroke 37:334; author reply 334-5. 2006
  54. ncbi request reprint Optimal INR for prevention of stroke and death in atrial fibrillation: a critical appraisal
    Anders Oden
    Statistical consultant, Romelanda, Sweden
    Thromb Res 117:493-9. 2006
    ..To study how stroke and mortality rates vary with different degrees of anticoagulation reflected by the international normalised ratio (INR) we critically assess information from different sources...
  55. ncbi request reprint Selecting patients with atrial fibrillation for anticoagulation: stroke risk stratification in patients taking aspirin
    Brian F Gage
    Division of General Medical Sciences, Washington University School of Medicine Campus Box 8005, 660 S Euclid Ave, St Louis, MO 63110, USA
    Circulation 110:2287-92. 2004
    ..This prospective cohort study tested the predictive accuracy of 5 stroke risk stratification schemes...
  56. ncbi request reprint Why is WASID an important clinical trial?
    Robert G Hart
    Neuroepidemiology 22:101-2. 2003
  57. ncbi request reprint Predictors of stroke in patients paced for sick sinus syndrome
    Arnold J Greenspon
    Division of Cardiology, Jefferson Medical College and Thomas Jefferson University Hospital, Philadelphia, Pennsylvania 19107, USA
    J Am Coll Cardiol 43:1617-22. 2004
    ..This study was an analysis of factors associated with stroke in a population of patients paced for sinus node dysfunction in a large prospective clinical trial (Mode Selection Trial [MOST])...
  58. ncbi request reprint Additive role of plasma von Willebrand factor levels to clinical factors for risk stratification of patients with atrial fibrillation
    Gregory Y H Lip
    Haemostasis, Thrombosis and Vascular Biology Unit, University Department of Medicine, City Hospital, Birmingham, England
    Stroke 37:2294-300. 2006
    ..This study determined the additive role of plasma vWf levels to clinical factors for risk stratification in patients with AF...
  59. ncbi request reprint Data and safety monitoring in clinical research: a National Institute of Neurologic Disorders and Stroke perspective
    Robin A Conwit
    National Institute of Neurological Disorders and Stroke, National Institutes of Health, Neuroscience Center, Bethesda, MD 20850, USA
    Ann Emerg Med 45:388-92. 2005
    ..We review National Institute of Neurologic Disorders and Stroke principles of data and safety monitoring and provide examples to illustrate key concepts...
  60. ncbi request reprint Serum potassium level and dietary potassium intake as risk factors for stroke
    Robert G Hart
    Neurology 60:1869-70; author reply 1870. 2003
  61. ncbi request reprint Clinical research in primary stroke prevention: needs, opportunities, and challenges
    Barbara Radziszewska
    National Institute of Neurological Disorders and Stroke, National Institutes of Health, 6001 Executive Boulevard, Bethesda, MD 20892, USA
    Neuroepidemiology 25:91-104. 2005
    ..The scientific or logistic barriers to stroke primary prevention trials are challenging, but are not insurmountable...
  62. ncbi request reprint Primary prevention of ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council: cosponsored by the Atherosclerotic Peripheral Vascular Disease Interdisciplinary Working Group; Cardiovascular Nursing Counc
    Larry B Goldstein
    Stroke 37:1583-633. 2006
    ..This guideline provides an overview of the evidence on various established and potential stroke risk factors and provides recommendations for the reduction of stroke risk...
  63. ncbi request reprint Primary prevention of ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council: cosponsored by the Atherosclerotic Peripheral Vascular Disease Interdisciplinary Working Group; Cardiovascular Nursing Counc
    Larry B Goldstein
    Circulation 113:e873-923. 2006
    ..This guideline provides an overview of the evidence on various established and potential stroke risk factors and provides recommendations for the reduction of stroke risk...